Page last updated: 2024-11-06

fluprazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

fluprazine: anti-aggressive agent in rats; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71153
CHEMBL ID2106753
SCHEMBL ID2110425
MeSH IDM0108784

Synonyms (26)

Synonym
(2-(4-(alpha,alpha,alpha-trifluoro-m-tolyl)-1-piperazinyl)ethyl)urea
urea, (2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-
fluprazine [inn]
fluprazina [inn-spanish]
fluprazinum [inn-latin]
fluprazine
2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethylurea
fluprazinum
fluprazina
unii-713bbl6840
76716-60-4
713bbl6840 ,
CHEMBL2106753
(2-(4-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-1-piperazinyl)ethyl)urea
MLS006011547
smr004703313
DTXSID70227545
SCHEMBL2110425
sr-01000945136
SR-01000945136-2
SR-01000945136-1
Z432843176
Q5462885
chqkhxjpwdstpy-uhfffaoysa-n
(2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)urea
EN300-1695993

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In the prechronic dose-response curve determination, fluprazine caused a dose-dependent decrease in postshock and intershock interval target biting behavior, increased the latency to the first attack, and decreased the number of attacks in the intruder-evoked aggression paradigm."( The effects of repeated administration of fluprazine on target biting and intruder-evoked attacks.
Carelli, RM; Wagner, GC, 1988
)
0.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (72.00)18.7374
1990's7 (28.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.34 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]